Norway· NO-ID_E6EE803E-9365-4D5F-8881-5DA1B2E01C51
Lorviqua
A lorlatinib product containing lorlatinib, registered in Norway by Pfizer Europe MA EEIG (1). The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Lorlatinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01ED05 (lorlatinib), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Lorlatinib · ATC L01ED05
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lorlatinib costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lorlatinib · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$192.44
The record
At a glance
FEST (Norway)- Active substance
- Lorlatinib
- Manufacturer
- Pfizer Europe MA EEIG (1)
- Country
- Norway (NO)
- ATC code
- L01ED05
- ATC class
- Lorlatinib
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_E6EE803E-9365-4D5F-8881-5DA1B2E01C51
- no_varenummer16994430NOK 70161.3
- gtin5415062334416
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
570 interactions on record for lorlatinib.
Graded by severity as the source publishes them — 119 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lorlatinib · interactions on record
570 records
- 119 severe
- 439 moderate
- 12 minor
Most severe, free to view
- LonafarnibA16AX20severe
- BerotralstatB06AC06severe
- VoxelotorB06AX03severe
- RanolazineC01EB18severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lorlatinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandLorviquaPfizer Europe MA EEIG
- United StatesLorbrenaPfizer Laboratories Div Pfizer Inc
- CzechiaLORVIQUAPfizer Europe MA EEIG, Bruxelles
- SpainLORVIQUA 100 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULAPfizer Europe Ma Eeig
- FranceLORVIQUA 100 mg, comprimé pelliculéPFIZER EUROPE MA EEIG (BELGIQUE)
- BelgiumLorviqua 100 mgPfizer Europe MA
- IcelandLorviquaPfizer Europe MA EEIG*
- NetherlandsLorviqua, 100 mg filmomhulde tablettenPfizer Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Lorviqua
- Liechtenstein · Lorviqua
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3ae33676-5cc2-413b-9f36-3e2c5cb6c041 GET /v1/drugs/3ae33676-5cc2-413b-9f36-3e2c5cb6c041?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, filmdrasjert",
"source": "fest",
"status": "A",
"atc_name": "Lorlatinib",
"merkevare_id": "ID_E6EE803E-9365-4D5F-8881-5DA1B2E01C51",
"name_form_strength": "Lorviqua tab 100 mg",
"prescription_group": "C"
}See everything about lorlatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.